Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995), including about retatrutide and Foundayo (orforglipron) as potential treatments for adults with obesity or type 2 diabetes and the timeline for future readouts, presentations, and other milestones relating to retatrutide and Foundayo and its clinical trials, and reflects Lilly's current beliefs and expectations
Diagnostics (Basel, Switzerland), 13 (20), 3172
As a result, semaglutide helps lower blood sugar levels and promotes weight loss
It further helps inhibit Tyrosinase activity (prevention of severe skin diseases), promotes pheomelanin synthesis, protects skin from harmful UV damage such as tanning and sunburns
Biocons Generics Business: Riding the GLP-1 Wave Biocons generics segment, which contributed 18% of the companys revenue , delivered an impressive 24% year-on-year growth , reaching 774 crore in Q2 FY26
Non-GLP-1 orals (metformin, Contrave) are included in the mail pharmacy at no extra cost